Nutrition and the biology of human ageing: Bone health & osteoporosis / sarcopenia / immune deficiency

Journal of Nutrition, Health and Aging

Volumn 17, Issue 8, 2013, Pages 712-716

  Offord, E A ^a   Karagounis, L G ^a   Vidal, K ^a   Fielding, R ^b   Meydani, S ^b   Penninger, J M ^c  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b TUFTS UNIVERSITY   (United States)

^c INSTITUTE OF MOLECULAR BIOTECHNOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; INFLUENZA VACCINE; OSTEOCLAST DIFFERENTIATION FACTOR; PROBIOTIC AGENT; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

AEROBIC EXERCISE; AGING; COMMON COLD; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFLAMMATION; LYCIUM; MUSCLE METABOLISM; NONHUMAN; NOTE; NUTRITION; OSTEOLYSIS; OSTEOPOROSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN INTAKE; REGULATORY MECHANISM; SARCOPENIA; SKELETAL MUSCLE;

AGED; AGING; ANIMALS; BONE AND BONES; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC DEFICIENCY SYNDROMES; MUSCLE, SKELETAL; NUTRITIONAL STATUS; OSTEOPOROSIS; SARCOPENIA;

EID: 84888009640     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-013-0374-3     Document Type: Note

References (70)

1. Johnell, O. and J.A. Kanis, An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int, 2006. 17(12): p. 1726-1733.
2. Kong, Y.Y., et al., OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature, 1999. 397(6717): p. 315-323.
3. Leibbrandt, A. and J.M. Penninger, RANK/RANKL: regulators of immune responses and bone physiology. Ann N Y Acad Sci, 2008. 1143: p. 123-150.
4. Vega, D., N.M. Maalouf, and K. Sakhaee, CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J Clin Endocrinol Metab, 2007. 92(12): p. 4514-4521.
5. Fata, J.E., et al., The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell, 2000. 103(1): p. 41-50.
6. Gonzalez-Suarez, E., et al., RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature. 468(7320): p. 103-7.
7. Schramek, D., et al., Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature. 468(7320): p. 98-102.
8. Karsenty, G., Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab, 2006. 4(5): p. 341-348.
9. Karsenty, G., The mutual dependence between bone and gonads. J Endocrinol. 213(2): p. 107-114.
10. Karsenty, G. and M. Ferron, The contribution of bone to whole-organism physiology. Nature. 481(7381): p. 314-320.
11. Greenhaff, P.L., et al., Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle. Am J Physiol Endocrinol Metab, 2008. 295(3): p. E595-E604.
12. Michailidis, Y., et al., Thiol-based antioxidant supplementation alters human skeletal muscle signaling and attenuates its inflammatory response and recovery after intense eccentric exercise. Am J Clin Nutr, 2013.
13. Lane, S.C., et al., Caffeine Ingestion and Cycling Power Output in a Low or Normal Muscle Glycogen State. Med Sci Sports Exerc, 2013.
14. Phillips, S.M., et al., Mixed muscle protein synthesis and breakdown after resistance exercise in humans. Am J Physiol Endocrinol Metab, 1997. 273(1): p. E99-107.
15. Chesley, A., et al., Changes in human muscle protein synthesis after resistance exercise. J Appl Physiol, 1992. 73(4): p. 1383-1388.
16. Biolo, G., et al., Increased rates of muscle protein turnover and amino acid transport after resistance exercise in humans. Am J Physiol Endocrinol Metab, 1995. 268(3): p. E514-E520.
17. Winder, W.W., et al., Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol, 2000. 88(6): p. 2219-2226.
18. Bergeron, R., et al., Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab, 2001. 281(6): p. E1340-E1346.
19. Bonewald, L.F., et al., Forum on bone and skeletal muscle interactions: Summary of the proceedings of an ASBMR workshop. J Bone Miner Res, 2013.
20. Szulc, P., et al., Low skeletal muscle mass is associated with poor structural parameters of bone and impaired balance in elderly men - the MINOS study. J Bone Miner Res, 2005. 20(5): p. 721-729.
21. Verbrugge, L.M. and A.M. Jette, The disablement process. Soc Sci Med, 1994. 38(1): p. 1-14.
22. Short, K.R., et al., Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A, 2005. 102(15): p. 5618-5623.
23. Cuthbertson, D., et al., Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J, 2005. 19(3): p. 422-424.
24. Ibebunjo, C., et al., Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia. Mol Cell Biol, 2013. 33(2): p. 194-212.
25. Rivas, D.A., et al., Increased ceramide content and NFkappaB signaling may contribute to the attenuation of anabolic signaling after resistance exercise in aged males. J Appl Physiol, 2012. 113(11): p. 1727-1736.
26. Fielding, R.A., et al., Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc, 2011. 12(4): p. 249-256.
27. Morley, J.E., et al., Sarcopenia. J Lab Clin Med, 2001. 137(4): p. 231-243.
28. Margetts, B.M., et al., Prevalence of risk of undernutrition is associated with poor health status in older people in the UK. Eur J Clin Nutr, 2003. 57(1): p. 69-74.
29. Vikstedt, T., et al., Nutritional status, energy, protein, and micronutrient intake of older service house residents. J Am Med Dir Assoc, 2011. 12(4): p. 302-307.
30. Cesari, M., et al., Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci, 2009. 64(3): p. 377-384.
31. Montero-Fernandez, N. and J.A. Serra-Rexach, Role of exercise on sarcopenia in the elderly. Eur J Phys Rehabil Med, 2013. 49(1): p. 131-143.
32. Kumar, V., et al., Muscle protein synthetic responses to exercise: effects of age, volume, and intensity. J Gerontol A Biol Sci Med Sci, 2012. 67(11): p. 1170-1177.
33. Goodpaster, B.H., et al., The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci, 2006. 61(10): p. 1059-1064.
34. Carlsson, M., et al., Effects of high-intensity exercise and protein supplement on muscle mass in ADL dependent older people with and without malnutrition: a randomized controlled trial. J Nutr Health Aging, 2011. 15(7): p. 554-560.
35. Rasmussen, B.B., et al., An oral essential amino acid-carbohydrate supplement enhances muscle protein anabolism after resistance exercise. J Appl Physiol, 2000. 88(2): p. 386-392.
36. Biolo, G., et al., An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein. Am J Physiol Endocrinol Metab, 1997. 273(1): p. E122-E129.
37. Moore, D.R., et al., Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men. Am J Clin Nutr, 2009. 89(1): p. 161-168.
38. Karagounis, L.G. and J.A. Hawley, Skeletal muscle: increasing the size of the locomotor cell. Int J Biochem Cell Biol, 2010. 42(9): p. 1376-1379.
39. Kimball, S.R. and L.S. Jefferson, Control of protein synthesis by amino acid availability. Curr Opin Clin Nutr Metab Care, 2002. 5(1): p. 63-67.
40. Anthony, J.C., et al., Signaling Pathways Involved in Translational Control of Protein Synthesis in Skeletal Muscle by Leucine. J. Nutr., 2001. 131(3): p. 856S-860S.
41. Anthony, J.C., et al., Orally Administered Leucine Stimulates Protein Synthesis in Skeletal Muscle of Postabsorptive Rats in Association with Increased eIF4F Formation. J. Nutr., 2000. 130(2): p. 139-145.
42. Pennings, B., et al., Amino acid absorption and subsequent muscle protein accretion following graded intakes of whey protein in elderly men. Am J Physiol Endocrinol Metab, 2012. 302(8): p. E992-E999.
43. Goodman, C.A., et al., A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy. Mol Biol Cell, 2010. 21(18): p. 3258-3268.
44. Bodine, S.C., et al., Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol, 2001. 3(11): p. 1014-1019.
45. Leenders, M., et al., Protein Supplementation during Resistance-Type Exercise Training in the Elderly. Med Sci Sports Exerc, 2013. 45(3): p. 542-552.
46. Chale, A., et al., Efficacy of Whey Protein Supplementation on Resistance Exercise-Induced Changes in Lean Mass, Muscle Strength, and Physical Function in Mobility-Limited Older Adults. J Gerontol A Biol Sci Med Sci, 2012.
47. Goberdhan, D.C., et al., Amino acid sensing and mTOR regulation: inside or out? Biochem Soc Trans, 2009. 37(Pt 1): p. 248-252.
48. Castle, S.C., et al., Host resistance and immune responses in advanced age. Clin Geriatr Med, 2007. 23(3): p. 463-479, v.
49. Gardner, I.D., The effect of aging on susceptibility to infection. Rev Infect Dis, 1980. 2(5): p. 801-810.
50. Cevenini, E., D. Monti, and C. Franceschi, Inflamm-ageing. Curr Opin Clin Nutr Metab Care. 16(1): p. 14-20.
51. Vasto, S., et al., Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev, 2007. 128(1): p. 83-91.
52. Weyand, C.M., J.W. Fulbright, and J.J. Goronzy, Immunosenescence, autoimmunity, and rheumatoid arthritis. Exp Gerontol, 2003. 38(8): p. 833-841.
53. Gay, R.T., et al., An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain. Proc Natl Acad Sci U S A, 2006. 103(37): p. 13825-13830.
54. Claesson, M.J., et al., Gut microbiota composition correlates with diet and health in the elderly. Nature. 488(7410): p. 178-184.
55. Hopkins, M.J. and G.T. Macfarlane, Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol, 2002. 51(5): p. 448-454.
56. Meydani, S.N., et al., Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr, 1990. 52(3): p. 557-563.
57. Meydani, S.N., et al., Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA, 1997. 277(17): p. 1380-1386.
58. Pallast, E.G., et al., Effect of 50- and 100-mg vitamin E supplements on cellular immune function in noninstitutionalized elderly persons. Am J Clin Nutr, 1999. 69(6): p. 1273-1281.
59. Hayek, M.G., et al., Vitamin E supplementation decreases lung virus titers in mice infected with influenza. J Infect Dis, 1997. 176(1): p. 273-276.
60. Meydani, S.N., et al., Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA, 2004. 292(7): p. 828-836.
61. Belisle, S.E., et al., Polymorphisms at cytokine genes may determine the effect of vitamin E on cytokine production in the elderly. J Nutr, 2009. 139(10): p. 1855-1860.
62. Meydani, S.N., et al., Serum zinc and pneumonia in nursing home elderly. Am J Clin Nutr, 2007. 86(4): p. 1167-1173.
63. Meydani, M., et al., Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J Nutr, 1991. 121(4): p. 484-491.
64. Meydani, S.N., et al., Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. J Clin Invest, 1993. 92(1): p. 105-113.
65. Wu, D., et al., Effect of concomitant consumption of fish oil and vitamin E on T cell mediated function in the elderly: a randomized double-blind trial. J Am Coll Nutr, 2006. 25(4): p. 300-306.
66. Gill, H.S., K.J. Rutherfurd, and M.L. Cross, Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol, 2001. 21(4): p. 264-271.
67. de Vrese, M., et al., Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr, 2005. 24(4): p. 481-491.
68. Vidal, K., et al., Intake of a milk-based wolfberry formulation enhances the immune response of young-adult and aged mice. Rejuvenation Res. 13(1): p. 47-53.
69. Ren, Z., et al., Dietary supplementation with lacto-wolfberry enhances the immune response and reduces pathogenesis to influenza infection in mice. J Nutr. 142(8): p. 1596-1602.
70. Vidal, K., et al., Immunomodulatory effects of dietary supplementation with a milkbased wolfberry formulation in healthy elderly: a randomized, double-blind, placebocontrolled trial. Rejuvenation Res. 15(1): p. 89-97.